We work from secure, dedicated, offices, and have extensive disaster recovery plans in place which involve real time off-site backup of all our operations and data. This ensures that – in the event of an emergency – all our critical pharmacovigilance processes can continue uninterrupted and guarantees that clients get a seamless service, plus peace of mind that their critical data is protected at all times.
We are responsible for licences in every European Union country, and in other countries around the world.
Two senior members of our management team have gained postgraduate qualifications in Pharmacovigilance, and others are currently studying for the same qualification.
We have extensive experience of inspections from the MHRA, the IMB, and the head of our Quality function also has experience of working with the FDA.
In addition to providing core pharmacovigilance services to companies at the clinical trial, Marketing Authorisation application and the post authorisation phases, we can also offer veterinary pharmacovigilance and medical device vigilance services.
We have a dedicated Quality Management function which ensures that all our work – at every level – is checked, audited, and compared with best practice and complies with the highest and latest standards.
We invest significantly in training. Each member of staff has modular training that is tailored to their role within Panacea and is modified if their responsibilities change. Training is updated on an annual basis or earlier, as necessary.
We place a premium on offering staff challenging and rewarding careers. Many of our staff have been with Panacea for many years; something which provides clients with exceptional continuity of service.